Concurrent quantitative HPLC–mass spectrometry profiling of small selenium species in human serum and urine after ingestion of selenium supplements
| Autor: | Kevin A. Francesconi, Sabine Kokarnig, Doris Kuehnelt, Tanja Wiesenhofer, Spiros A. Pergantis, Verena Lackner, Alexandra Tsirigotaki |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male Time Factors Metabolite chemistry.chemical_element Urine Biochemistry Selenate Mass Spectrometry Inorganic Chemistry Excretion Selenium Young Adult chemistry.chemical_compound Humans Ingestion Chromatography High Pressure Liquid Chromatography Reverse-Phase Chromatography Middle Aged Chromatography Ion Exchange Bioavailability Methylselenocysteine chemistry Dietary Supplements Metabolome Molecular Medicine Female |
| Zdroj: | Journal of Trace Elements in Medicine and Biology. 29:83-90 |
| ISSN: | 0946-672X |
| DOI: | 10.1016/j.jtemb.2014.06.012 |
| Popis: | Selenium metabolic patterns in the human body originating from five distinct selenium dietary sources, selenate, selenite, selenomethionine (SeMet), methylselenocysteine (MeSeCys) and selenized yeast, were investigated by performing concurrent HPLC-mass spectrometric analysis of human serum and urine. Total selenium and selenium species time profiles were generated by sampling and analyzing serum and urine from volunteers treated with selenium supplements, up to 5 and 24h following ingestion, respectively. We found that an increase in total serum selenium levels, accompanied by elevated selenium urinary excretion, was the common pattern for all treatments, except for that of selenite supplementation. Selenosugar 1 was a universal serum metabolite in all treatments, indicating that ingested selenium is favorably metabolized to the sugar. Except for selenite and selenized yeast ingestion, these patterns were reflected in the urine time series of the different treatments. Selenosugar 1 was the major selenium species present in urine in all treatments except for the selenate treatment, accounting for about 80% of the identified excreted species within 24h of ingestion. Furthermore, the urinary metabolite trimethylselenonium ion (TMSe) was detected for the first time in human background serum by using HPLC coupled to elemental and molecular mass spectrometry. The concurrent monitoring of non-protein selenium species in both body fluids provides the relation between bioavailability and excretion of the individual ingested species and of their metabolic products, while the combined use of elemental and molecular mass spectrometry enables the accurate quantitation of structurally confirmed species. This successfully applied approach is anticipated to be a useful tool for more extensive future studies into human selenium metabolism. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect